Jeffrey Scott Riley, CEO and President at Synthetic Biologics, Inc. (SYN), bought 2,900 shares at $0.17 ($501) on 2013-01-07, disclosed to the SEC on 2013-01-07.
Open-market purchase of $501 SYN by CEO and President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.17 | 2,895 | $492 | 98.3% |
| 2 | $1.71 | 5 | $9 | 1.7% |
| Total | $0.17 avg | 2,900 | $501 | 100% |
| Filing → |
| SYN | BUY | 2013-01-03 | $10K | — | Filing → |